Pharma and Biotech
Year End | Type | Amount | Payment Date | Ex-Div Date | Record Date |
---|---|---|---|---|---|
30-Sep-20 | Interim | 00.00 | |||
Final | 00.00 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 23.80p |
Change Today | 1.80p |
% Change | 8.18 % |
52 Week High | 45.85p |
52 Week Low | 17.70p |
Volume | 2,445,829 |
Shares Issued | 741.51m |
Market Cap | £176.48m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:13 | 4,131 @ 23.80p |
13:13 | 55,387 @ 23.80p |
13:13 | 132,113 @ 23.80p |
12:36 | 33,333 @ 23.80p |
11:32 | 30,000 @ 23.75p |
CFO | Septima Maguire |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research